公司资料
Vaccinex 股价、新闻与催化剂
- 股票代码:
- VCNX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.78 USD (-6.83%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
Current closing-price context is not available for VCNX.
公司概览
业务概览
Vaccinex is a biotechnology company focused on antibody therapies and immunology, with a history of pursuing difficult oncology and neurodegenerative targets. Its story is tied to platform science and the challenge of turning it into durable value.
所在地与行业分类
Vaccinex is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with a therapeutic platform focus.
商业模式特征
The business model depends on clinical validation, strategic partnerships, and capital management. Investors typically track early data, platform breadth, and whether the company can progress a narrow pipeline without dilution pressure.
生物医药行业定位
Vaccinex sits in a high-risk platform-biotech niche. It remains catalyst-sensitive because the company's value depends on a limited number of programs and the market's belief in its science.
未来催化剂
- Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame. That breadth is useful, but the company now needs one of those programs to move from scientific promise to something more concrete.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。